Thalidomide treatment modulates macrophage pro-inflammatory function and cytokine levels in Klebsiella pneumoniae B5055 induced pneumonia in BALB/c mice

International Immunopharmacology

Volumn 10, Issue 7, 2010, Pages 777-783

  Kumar, Vijay ^a   Harjai, Kusum ^a   Chhibber, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acute lung inflammation; Alveolar macrophages; Cytokines; Klebsiella pneumoniae B5055; Macrophage spreading; Phagocytosis

Indexed keywords

HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; SODIUM CHLORIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; BAGG ALBINO MOUSE; CELL SPREADING; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR KILLING; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; CYTOKINES; INFLAMMATION MEDIATORS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; PHAGOCYTOSIS; PNEUMONIA; THALIDOMIDE;

EID: 77953028084     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.008     Document Type: Article

References (33)

1. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
2. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. N Eng J Med 353 (2005) 1685-1693
3. Toews G.B. Cytokines and the lung. Eur Respir J 18 Suppl 34 (2001) 3S-17S
4. Jeeyaseelan S., Chu H.W., Young S.K., and Worthen G.S. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 72 12 (2004) 7247-7256
5. Abraham E., Carmody A., Shenkar R., and Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol 279 (2000) L1137-L1145
6. Abraham E. Neutrophils and acute lung injury. Crit Care Med 31 (2003) S195-S199
7. Woo P.C.Y., Pau S.K.P., and Yuen K.-Y. Macrolides as immunomodulatory agents. Curr Med Chem-Anti-inflamm Anti-Allergy Agents 1 (2002) 131-141
8. Thomas L. Infectious diseases: the effects of cortisone and adrenocorticotropic hormone on infection. Ann Rev Med 3 (1952) 1-24
9. Tasaka S., Hasegawa N., and Ishizaka A. Pharmacology of acute lung injury. Pulm Pharmacol Ther 15 (2002) 83-95
10. Mellin G.W., and Katzenstein M. The saga of thalidomide (concluded): neuropathy to embryopathy, with case reports of congenital anomalies. N Eng J Med 267 (1962) 1238-1244
11. Calabrese L., and Fleischer Jr. A.B. Thalidomide: current and potential clinical applications. Am J Med 108 (2000) 487-495
12. Mujagic H., Chabner B.A., and Mujagic Z. Mechanism of action and potential therapeutic uses of thalidomide. Croat Med J 43 3 (2002) 274-285
13. Kumar V., and Chhibber S. Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB/c mice. Eur J Pharmacol 592 (2008) 146-150
14. Held T.K., Miellke M.E.A., Chedid M., et al. Granulocyte colony stimulating factor worsens the outcome of the experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91 (1998) 2525-2533
15. Yadav V., Sharma S., Harjai K., and Chhibber S. Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in the mice. Ind J Med Res 118 (2003) 47-52
16. Laichalk L.L., Kunkel S.L., Streiter R.M., Danforth J., and Standiford T.J. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 64 (1996) 5211-5218
17. Allen P.H., Fisher D., Saunders J.R., and Hart C.A. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing. J Med Microbiol 24 (1987) 363-370
18. Rabinovitch M., Manejias R.E., Russo M., et al. Increased spreading of macrophages from mice treated with interferon inducers. Clin Immunol 29 (1977) 86-95
19. Arruda M.S.P., Richini V.B., Oliveria S.M.A., and Villani-Moreno F.R. Experimental murine mycobacteriosis: evaluation of the functional activity of alveolar macrophages in the thalidomide treated mice. Braz J Med Biol Res 37 (2004) 485-492
20. Pick E., and Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Imunological Methods 46 (1981) 211-226
21. Standiford T.J., Mehrad B., Tsai W.C., and Moore T.A. Pulmonary host defenses: the role of cytokines in mediating lung inflammation. Medscape General Med 1 3 (1999)
22. Johnston Jr. R.B. Monocytes and macrophages. N Eng J Med 318 (1988) 747
23. Meierhoefer C., Duzendorfer S., and Wiedermann C.J. Protein kinase C-dependent effects on leukocyte migration of thalidomide. J Infect Dis 180 (1999) 216-219
24. Sampaio S.C., Sousa-e-Silva M.C.C., Borelli P., and Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J Leukoc Biol 70 (2001) 551-557
25. Vilani-Moreno F.R., Fecchio D., de Matoss M.C.I., Moscardi-Bacchi M., Defaveri J., and Franco M. Study of pulmonary experimental paracoccidioidomycosis by analysis of bronchoalveolar lavage cells: resistant vs. susceptible mice. Mycopathologia 141 (1998) 79-91
26. Kooguchi K., Hashimoto S., Kobayashi A., Kitamura Y., Kudoh I., Wiener-Kronish J., et al. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect Immun 66 7 (1998) 3164-3169
27. Geitz H., Handt S., and Zwingenberger K. Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacol 31 (1996) 213-221
28. Chen C.-S., Perng W.-C., Chen C.-W., Huang K.-L., Wu C.-P., and Yen M.-H. Thalidomide prevents LPS/Zymosan induced acute lung injury in rats. J Biomed Sci 11 (2004) 591-598
29. Lindsey L., Oliver S.J., Freeman S.L., Josien R., Krauss A., and Kaplan G. Modulation of hyperoxia-induced TNF-α expression in the newborn rat lung by thalidomide and dexamethasone. Inflammation 24 (2000) 347-356
30. 2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J Immunol 168 (2002) 2644-2651
31. Ye Q., Chen B., Tong Z., Nakamura S., Sarria R., Costable U., et al. Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease. Eur Respir J 28 (2006) 824-831
32. Corral L.G., Haslett P.A.J., Muller G.W., Chen R., Lu-Min W., Patterson R.T., et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α. J Immunol 163 (1999) 380-386
33. Noman A.S.M., Koide N., Hassan F., E-Khuda I.I., Dagvadroj J., Tumurkhuu G., et al. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-α production via down-regulation of MyD88 expression. Innate Immun 15 1 (2009) 33-41